Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
10/29/1985 | CA1195924A1 Depyrogenation process |
10/24/1985 | WO1985004673A1 Novel dna and its use |
10/24/1985 | WO1985004662A1 Leukoregulin, an antitumor lymphokine, and its therapeutic uses |
10/24/1985 | WO1985004654A1 A peptide vaccine or diagnostic, and a polypeptide useful therefor |
10/24/1985 | WO1985004653A1 Antibodies to human interleukin-2 induced by synthetic polypeptides |
10/24/1985 | WO1985004588A1 Live purified marek's disease vaccine and process for the preparation thereof |
10/24/1985 | WO1985004587A1 RECOMBINANT HERPES SIMPLEX gB-gD VACCINE |
10/24/1985 | WO1985004578A1 Steroidal liposomes |
10/23/1985 | EP0159311A1 Method for inactivating pathogens in blood products |
10/23/1985 | EP0159003A2 Method for purification of filamentous hemagglutinin |
10/23/1985 | EP0158973A2 Multisite immunometric assay |
10/23/1985 | EP0158880A2 Liposomes with inhalable allergens for treatment of allergies, method for their preparation and pharmaceutical compositions containing them |
10/23/1985 | EP0158746A2 Visualization method for the direct or indirect detection of the reaction between a specific binding agent and the corresponding acceptor substance in blot overlay assays |
10/23/1985 | EP0060871B1 Monoclonal antibodies specific for human hematopoietic cell surface glycoproteins |
10/22/1985 | US4549011 Cyanuric chloride |
10/22/1985 | US4548922 Steroid increasespermeability of surface to drug |
10/22/1985 | US4548909 Identifying infections prior to symptoms by complexing immune complexes and labelled antigen-specific reagants |
10/16/1985 | EP0158599A2 Monoclonal antibodies and hybridoma cells, process for preparing them and their use |
10/16/1985 | EP0158284A2 Process for obtaining parasites antigens |
10/16/1985 | EP0158282A2 Vaccine and serum for endotoxin associated disease and method of preparing same as well as methods of immunisation and treatment of such disease and to a detoxified endotoxin and bacterial mutant |
10/16/1985 | EP0158179A2 Antibiotic 6270, process for its production, and its use as an anticoccidiosis agent and a feed additive |
10/16/1985 | EP0157899A2 Multivalent pneumococcal vaccine and preparation thereof |
10/15/1985 | US4547368 Administered as vaccine to primates |
10/15/1985 | US4547367 Centrifuging and isolation from liver; mixing with adjevant and injecting |
10/15/1985 | CA1195269A1 Cancer cell-combatting lymphocytes, process for the production thereof and anticancer agents containing said lymphocytes |
10/15/1985 | CA1195248A1 Anti-cancer drugs for the treatment of melanomas and method for preparing thereof |
10/10/1985 | WO1985004422A1 Antibodies, manufacture and use |
10/10/1985 | WO1985004397A1 Platelet related growth regulator |
10/10/1985 | CN85100848A Method for preparating of babesia bovis vaccine |
10/09/1985 | EP0157753A1 New somatostatin compounds, process for their synthesis, preparation for veterinary use containing said compound and process for the treatment of animals |
10/09/1985 | EP0157643A2 Antibodies to human interleukin-2 induced by synthetic polypeptides |
10/09/1985 | EP0157574A2 Antitetanic antibody producing human-human hybridoma and method of producing the same |
10/09/1985 | EP0157572A2 Acyltripeptide immunostimulants |
10/09/1985 | EP0157528A2 Attenuated smallpox vaccine strain |
10/09/1985 | EP0157427A2 Process for preparing glycosidic linkage related antigen |
10/08/1985 | US4545987 Psoralen inactivated double-stranded RNA viral vaccines |
10/08/1985 | US4545986 Timothy grass antigen specific anti-idiotypic antibodies |
10/08/1985 | US4545931 Synthetic heat-stable enterotoxin polypeptide of Escherichia coli |
10/08/1985 | CA1194794A1 Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom |
10/08/1985 | CA1194792A1 Non-a, non-b hepatitis-associated monoclonal antibody and diagnostic reagent |
10/02/1985 | EP0156712A1 Useful composition for the manufacture of vaccines containing particles bearing a hepatitis B virus surface antigen and polymerized human seric albumin receptor, animal cells able toproduce such particles and process for their obtention |
10/02/1985 | EP0156633A1 Composition for prevention and treatment of mycoplasmal pneumonia |
10/02/1985 | EP0156578A2 A process for preparing hybridoma cells which produce tumour specific monoclonal antibodies |
10/02/1985 | EP0156537A2 Biological magnetic fluids |
10/02/1985 | EP0156478A2 Propagation of group II avian adeno (AA) virus in avian cell culture and vaccine produced |
10/02/1985 | EP0156299A2 LTR modified viral vaccines |
10/02/1985 | EP0156296A1 Automated immunoassay |
10/02/1985 | EP0156242A2 Lyophilized hepatitis B vaccine |
10/02/1985 | EP0155943A1 A method of determining changes occurring in cartilage |
10/01/1985 | US4544550 Method for the treatment of diabetes |
10/01/1985 | US4544548 Method for the control of coccidiosis in poultry |
10/01/1985 | US4544500 Polypeptide |
10/01/1985 | CA1194415A1 Immunoglobulin half-molecules and process for producing hybrid antibodies |
09/26/1985 | WO1985004256A1 Immunofixation electrophoresis process |
09/26/1985 | WO1985004187A1 Process for preparing 5'-guanylic acid |
09/26/1985 | WO1985004169A1 Method and agents for measuring protein aging |
09/26/1985 | WO1985004103A1 Synthetic hepatitis b virus vaccine including both t cell anc b cell determinants |
09/25/1985 | EP0155790A1 Vaccine for swine dysentery |
09/25/1985 | EP0155388A2 Enzyme-protein conjugate, process for its preparation and pharmaceutical use thereof |
09/24/1985 | US4543340 Radioimmunoassay of thymosin β4 |
09/24/1985 | US4543253 Solidified pharmaceutical composition comprising cell wall skeleton |
09/24/1985 | US4543211 Binding immunoglobulin to polymer |
09/18/1985 | EP0155252A2 Immunoreactive solid phase |
09/18/1985 | EP0155235A2 Treatment of vernal conjunctivitis |
09/18/1985 | EP0155224A2 Solid-borne complex bearing chromagen responsive functionality for antibody, antigen, receptor, or ligand detection |
09/18/1985 | EP0155198A1 Yeast cloning and expression vectors for a protein in an eucaryotic cell, containing at least a part of a retrovirus genome; transfected eucaryotic cells; process using these cells and obtained proteins |
09/18/1985 | EP0155172A2 Anti-human lung cancer monoclonal antibodies |
09/18/1985 | EP0155147A2 The antigenic determinants of HBxAg |
09/18/1985 | EP0155146A2 Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
09/18/1985 | EP0155104A2 Free analyte assay |
09/18/1985 | EP0155007A2 Method for purification of HBs antigen |
09/18/1985 | EP0154902A2 Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
09/18/1985 | EP0154884A2 Nucleic acid-protein conjugate |
09/18/1985 | EP0154788A2 Detectable molecules, method of preparation and use |
09/17/1985 | US4542225 Acid-cleavable compound |
09/17/1985 | US4542069 Carriers for biologically active materials |
09/17/1985 | US4542017 Interleukins to stimulate metabolism |
09/17/1985 | US4542016 Non-a non-b hepatitis surface antigen useful for the preparation of vaccines and methods of use |
09/17/1985 | CA1193565A1 Method of preparing an immunogen of pasteurella multocida |
09/17/1985 | CA1193563A1 Expression vectoer of the antigenic proein of rabies and use for the preparation of vaccines |
09/17/1985 | CA1193562A1 Human hybridomas, precursors and products |
09/17/1985 | CA1193545A1 Virus vaccines and process for preparing the same |
09/12/1985 | WO1985003950A1 A sv40 expression vector containing hbxag as an expression marker |
09/12/1985 | WO1985003947A1 T-cell receptor-specific for antigen polypeptides and related polynucleotides |
09/12/1985 | WO1985003876A1 Composition useful for obtaining vaccines containing particles carrying the surface antigene of hepatitis b virus and the recepto r of polymerized human serum albumin, animal cells capable of p roducing such particles and method for the obtention thereof |
09/12/1985 | WO1985003875A1 Vaccine for swine dysentery |
09/11/1985 | EP0154587A2 Fragments of DNA which encode peptides capable of inducing in vivo the synthesis of anti-hepatitis A virus antibodies |
09/11/1985 | EP0154549A2 Anticariogenic or antiperiodontitic agent |
09/11/1985 | EP0154454A1 Cloning of DNA for protozoal antigens |
09/11/1985 | EP0154133A2 Plasmidic expression vehicles, and method of producing a polypeptide therewith |
09/11/1985 | EP0154064A1 Toxins and antibodies of C. difficile |
09/11/1985 | EP0153939A1 Vaccine and antigen against paludism and preparation process thereof |
09/10/1985 | US4540669 Herpes simplex type I subunit vaccine |
09/10/1985 | US4540660 Substrate for fluoroimmunoassay of biological fluids |
09/10/1985 | US4540573 Undenatured virus-free biologically active protein derivatives |
09/10/1985 | CA1193216A1 Process for preparing conjugated haptens and muramyl-peptides useful as immunogenic agents, and compositions containing the same |
09/10/1985 | CA1193210A1 Human hepatoma derived cell line, process for preparation thereof, and uses therefor |
09/04/1985 | EP0153871A2 Antibody enhancement of immunogenicity of antigen |
09/04/1985 | EP0153710A2 Novel toxoids of elastase of pseudomonas aeruginosa origin |
09/04/1985 | EP0153519A1 Toxins and antibodies of C. difficile |